These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 6823212

  • 21. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G, Schütte W, Berg W, Möller T.
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [Abstract] [Full Text] [Related]

  • 22. A biochemical basis for grouping of patients with urolithiasis.
    Tiselius HG, Almgård LE, Larsson L, Sörbo B.
    Eur Urol; 1978 Jul; 4(4):241-9. PubMed ID: 668734
    [Abstract] [Full Text] [Related]

  • 23. Circadian variations in the risk of urinary calcium oxalate stone formation.
    Robert M, Roux JO, Bourelly F, Boularan AM, Guiter J, Monnier L.
    Br J Urol; 1994 Sep; 74(3):294-7. PubMed ID: 7953257
    [Abstract] [Full Text] [Related]

  • 24. [Studies on calcium oxalate crystal formation in urolithiasis. Multi-regressive analysis of urinary CaOx crystalline volumes and the effects of urinary various substances on CaOx crystal formation].
    Kataoka K, Umekawa T, Katayama Y, Ishikawa Y, Kodama M, Takamura C, Takada M, Kato Y, Hohri K, Iguchi M.
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):799-803. PubMed ID: 1875573
    [Abstract] [Full Text] [Related]

  • 25. Metabolic risk factors in pediatric and adult calcium oxalate urinary stone formers: is there any difference?
    Tefekli A, Esen T, Ziylan O, Erol B, Armagan A, Ander H, Akinci M.
    Urol Int; 2003 May; 70(4):273-7. PubMed ID: 12740490
    [Abstract] [Full Text] [Related]

  • 26. Essential arterial hypertension and stone disease.
    Borghi L, Meschi T, Guerra A, Briganti A, Schianchi T, Allegri F, Novarini A.
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [Abstract] [Full Text] [Related]

  • 27. Magnesium excretion and calcium oxalate urolithiasis.
    Resnick MI, Munday D, Boyce WH.
    Urology; 1982 Oct; 20(4):385-9. PubMed ID: 7147507
    [Abstract] [Full Text] [Related]

  • 28. [A study on the cause of urolithiasis of the upper urinary tract--clinical study of risk factors in the formation of stones in the upper urinary tract].
    Nonomura M, Kawamura J, Ueda M, Okada Y, Takeuchi H, Yoshida O.
    Hinyokika Kiyo; 1986 Mar; 32(3):311-25. PubMed ID: 3728237
    [Abstract] [Full Text] [Related]

  • 29. Increased dietary oxalate does not increase urinary calcium oxalate saturation in hypercalciuric rats.
    Bushinsky DA, Bashir MA, Riordon DR, Nakagawa Y, Coe FL, Grynpas MD.
    Kidney Int; 1999 Feb; 55(2):602-12. PubMed ID: 9987084
    [Abstract] [Full Text] [Related]

  • 30. Predictive value of some biochemical indices in stone formers.
    Hussain F, Billimoria FR, Singh PP.
    Int Urol Nephrol; 1990 Feb; 22(1):25-31. PubMed ID: 2380000
    [Abstract] [Full Text] [Related]

  • 31. [Calcium oxalate activity products and discriminant analysis of urinary parameters as basis for a calcium oxalate screening program (author's transl)].
    Brundig P, Berg W, Naumann J, Hoppe H, Cumme GA, Achilles W, Schneider HJ.
    Urologe A; 1980 Jan; 19(1):54-6. PubMed ID: 7355530
    [Abstract] [Full Text] [Related]

  • 32. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
    Tiselius HG, Ahlstrand C, Larsson L.
    Urol Res; 1980 Jan; 8(4):197-206. PubMed ID: 7222314
    [Abstract] [Full Text] [Related]

  • 33. [Clinical studies on the recurrence of urolithiasis (5). Diurnal variation in urinary pH and stone compositions].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1988 Oct; 34(10):1711-5. PubMed ID: 3245520
    [Abstract] [Full Text] [Related]

  • 34. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T, Taguchi H.
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [Abstract] [Full Text] [Related]

  • 35. [Investigations on formation risk of calcium oxalate stones with special regard to stress (author's transl)].
    Brundig P, Berg W, Schneider HJ.
    Urol Int; 1979 Sep; 34(2):105-13. PubMed ID: 442282
    [Abstract] [Full Text] [Related]

  • 36. Promoters and inhibitors of calcium urolithiasis in children.
    Lama G, Carbone MG, Marrone N, Russo P, Spagnuolo G.
    Child Nephrol Urol; 1990 Sep; 10(2):81-4. PubMed ID: 2253256
    [Abstract] [Full Text] [Related]

  • 37. [Studies on oxalate in urolithiasis. II. Urinary oxalate in oxalate stone-formers (author's transl)].
    Ogawa Y.
    Nihon Hinyokika Gakkai Zasshi; 1981 Dec; 72(12):1546-52. PubMed ID: 7345192
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of verapamil on urinary calcium and oxalate excretion in renal stone formers].
    Iguchi M, Ikegami M, Kiwamoto H, Umekawa T, Ishikawa Y, Kohri K, Kurita T.
    Hinyokika Kiyo; 1993 May; 39(5):425-31. PubMed ID: 8322624
    [Abstract] [Full Text] [Related]

  • 39. Calcium stones: the difference between oxalate and phosphate types.
    Elliot JS.
    J Urol; 1968 Nov; 100(5):687-93. PubMed ID: 5682550
    [No Abstract] [Full Text] [Related]

  • 40. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
    Lagemann M, Anders D, Graef V, Bödeker RH.
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.